Evaluation of a free 3D software for kidney stones' surgical planning: "kidney stone calculator" a pilot study.


Journal

World journal of urology
ISSN: 1433-8726
Titre abrégé: World J Urol
Pays: Germany
ID NLM: 8307716

Informations de publication

Date de publication:
Sep 2021
Historique:
received: 06 12 2020
accepted: 13 03 2021
pubmed: 30 3 2021
medline: 29 1 2022
entrez: 29 3 2021
Statut: ppublish

Résumé

Kidney Stone Calculator (KSC) is a free, three-dimensional (3D) planning software for flexible ureteroscopy(fURS) with Holmium:YAG(Ho:YAG) endocorporeal lithotripsy (EL). KSC provides the stone volume (SV) and expected duration of lithotripsy (ExDL) estimations based on non-enhanced-CT scan (NECT) DICOM series. We aimed to provide a preclinical and clinical evaluation of KSC. A preclinical evaluation measured the SV by three operators (resident, endourology expert and research engineer) among 17 NECT cases. Between January and March 2020, a multicentric, prospective, observational double-blind clinical evaluation was conducted in patients presenting with renal stones treated with Ho:YAG-EL during fURS and preoperative NECT. Demographic and surgical data were collected. The primary endpoint was a significant median difference between ExDL and EffectiveDL (EfDL). Second, efficiency (J/mm The preclinical evaluation showed no significant difference in the SV measurements among operators (p > 0.05). Pearson and Kendall coefficients of 0.99 and 0.98, respectively, were found. Twenty-six patients were included in the clinical evaluation, with a median age of 55 years. In 66% of cases, there was a single stone located in the lower pole, with a density > 1000 Hounsfield Unit observed in 42% and 85% of cases. A 14% [Q1-Q3 (5.4-24.8); p = 0.36] median difference between ExDL and EfDL was noted, which was greater in the case of lower pole stones with no possible relocation (p = 0.008). Median values of 17.6 J/mm Kidney Stone Calculator is a reproducible and accurate software that allows for an estimation of the stone burden and provides an ExDL for URSf. Defining the influencing factors of EL will improve its ExDL.

Identifiants

pubmed: 33779821
doi: 10.1007/s00345-021-03671-z
pii: 10.1007/s00345-021-03671-z
pmc: PMC8006641
doi:

Types de publication

Journal Article Multicenter Study Observational Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

3607-3614

Informations de copyright

© 2021. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.

Références

World J Urol. 2021 Mar;39(3):891-896
pubmed: 32462304
J Endourol. 2018 Mar;32(3):265-266
pubmed: 29385816
World J Urol. 2021 Jun;39(6):1673-1682
pubmed: 33067728
Magn Reson Imaging. 2012 Nov;30(9):1323-41
pubmed: 22770690
Prog Urol. 2020 Jun - Jul;30(8-9):439-447
pubmed: 32430140
Nat Rev Urol. 2018 Nov;15(11):653-654
pubmed: 29921906
Eur Urol. 2016 Mar;69(3):475-82
pubmed: 26344917
J Endourol. 2010 Sep;24(9):1411-4
pubmed: 20629563
Sci Rep. 2017 May 17;7(1):2049
pubmed: 28515418
Eur Urol Focus. 2021 May;7(3):589-590
pubmed: 32591284
Int Braz J Urol. 2019 Sep-Oct;45(5):948-955
pubmed: 31268643
Int J Mol Sci. 2018 Oct 01;19(10):
pubmed: 30275370
Nat Rev Urol. 2016 Nov;13(11):654-662
pubmed: 27578040
Urology. 2015 Sep;86(3):477-81
pubmed: 26135811
World J Urol. 2021 Jun;39(6):1683-1691
pubmed: 32253581
Urology. 2011 Aug;78(2):282-5
pubmed: 21296390
J Endourol. 2018 Aug;32(8):685-691
pubmed: 29890914
J Urol. 2011 Dec;186(6):2275-9
pubmed: 22014818
Prog Urol. 2020 May;30(6):339-345
pubmed: 32312624
Radiology. 2003 Sep;228(3):864-70
pubmed: 12954901
World J Urol. 2021 Jan;39(1):187-194
pubmed: 32270283
Eur Urol. 2012 Jul;62(1):160-5
pubmed: 22498635
Prog Urol. 2018 Jan;28(1):62-70
pubmed: 29102376
J Endourol. 2018 Jul;32(7):659-664
pubmed: 29860872
Radiology. 2005 Jun;235(3):850-6
pubmed: 15914478
World J Urol. 2020 Nov;38(11):2945-2953
pubmed: 31989208
Urolithiasis. 2014 Apr;42(2):95
pubmed: 24317839
J Urol. 2016 Oct;196(4):1153-60
pubmed: 27238616
Radiology. 2011 Mar;258(3):915-22
pubmed: 21339353

Auteurs

Frédéric Panthier (F)

Service D'Urologie, Hôpital Européen Georges Pompidou, AP-HP, Centre-Université de Paris, 20 rue Leblanc, 75015, Paris, France. fredericpanthier@gmail.com.
GRC n°20, Groupe de Recherche Clinique Sur La Lithiase Urinaire, Hôpital Tenon, Sorbonne Université, 75020, Paris, France. fredericpanthier@gmail.com.

Olivier Traxer (O)

GRC n°20, Groupe de Recherche Clinique Sur La Lithiase Urinaire, Hôpital Tenon, Sorbonne Université, 75020, Paris, France.
Service D'Urologie, Hôpital Tenon, AP-HP, Sorbonne Université, 4 rue de la Chine, 75020, Paris, France.
PIMMUMR 8006 CNRS-Arts Et Métiers ParisTech, 151 bd de l'Hôpital, 75013, Paris, France.

Laurent Yonneau (L)

Service D'Urologie, Hôpital Foch-Université Paris Saclay-UVSQ, 40 rue Worth, 92150, Suresnes, France.

Thierry Lebret (T)

Service D'Urologie, Hôpital Foch-Université Paris Saclay-UVSQ, 40 rue Worth, 92150, Suresnes, France.

Laurent Berthe (L)

PIMMUMR 8006 CNRS-Arts Et Métiers ParisTech, 151 bd de l'Hôpital, 75013, Paris, France.

Lounès Illoul (L)

PIMMUMR 8006 CNRS-Arts Et Métiers ParisTech, 151 bd de l'Hôpital, 75013, Paris, France.

Marc-Olivier Timsit (MO)

Service D'Urologie, Hôpital Européen Georges Pompidou, AP-HP, Centre-Université de Paris, 20 rue Leblanc, 75015, Paris, France.

Arnaud Mejean (A)

Service D'Urologie, Hôpital Européen Georges Pompidou, AP-HP, Centre-Université de Paris, 20 rue Leblanc, 75015, Paris, France.

Steeve Doizi (S)

GRC n°20, Groupe de Recherche Clinique Sur La Lithiase Urinaire, Hôpital Tenon, Sorbonne Université, 75020, Paris, France.
Service D'Urologie, Hôpital Tenon, AP-HP, Sorbonne Université, 4 rue de la Chine, 75020, Paris, France.
PIMMUMR 8006 CNRS-Arts Et Métiers ParisTech, 151 bd de l'Hôpital, 75013, Paris, France.

François Audenet (F)

Service D'Urologie, Hôpital Européen Georges Pompidou, AP-HP, Centre-Université de Paris, 20 rue Leblanc, 75015, Paris, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH